Inhibition of TNF-α induced cell death in human umbilical vein endothelial cells and Jurkat cells by protocatechuic acid

被引:16
作者
Zhou-Stache, J
Buettner, R
Artmann, G
Mittermayer, C
Bosserhoff, AK [1 ]
机构
[1] Univ Aachen, Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany
[2] FH Aachen Abt Julich, Dept Cell Biophys, Aachen, Germany
[3] Univ Regensburg, Inst Pathol, D-8400 Regensburg, Germany
关键词
cell death; NF-kappa B; protocatechuic acid; TNF-alpha; human umbilical vein endothelial cells; Jurkat cells;
D O I
10.1007/BF02345308
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
The Chinese herb radix Salviae miltiorrhizae (RSM) is used in traditional Chinese medicine as a treatment for cardiovascular and cerebrovascular diseases. Several components of the plant extract from salvia mitorrhiza bunge have been determined previously, one of which is protocatechuic acid (PAC). It has been found, in the study, that PAC inhibited TNF-alpha-induced cell death of human umbilical vein endothelial cells (HUVECs) and Jurkat cells in a concentration of 100muM when applied 2 h prior to TNF-alpha exposure. Molecular studies revealed that PAC activated NF-kappaB with a maximum effect after 30 min of treatment. Inhibition of NF-kappaB action by MG 132 and NF-kappaB inhibitory peptide suppressed the cell-protective effect of PAC. Further, degradation of IkBalpha occurred in response to PAC treatment The results provide evidence that activation of NF-kappaB plays an important role in mediating the cell-protecting effect of PAC on HUVECs and Jurkat cells. Further studies are required to test whether PAC, a component of radix salviae miltiorrhizae, could be useful in preventing in vivo cell death resulting from cardiovascular or cerebrovascular diseases.
引用
收藏
页码:698 / 703
页数:6
相关论文
共 36 条
[1]   STIMULATION-DEPENDENT I-KAPPA-B-ALPHA PHOSPHORYLATION MARKS THE NF-KAPPA-B INHIBITOR FOR DEGRADATION VIA THE UBIQUITIN-PROTEASOME PATHWAY [J].
ALKALAY, I ;
YARON, A ;
HATZUBAI, A ;
ORIAN, A ;
CIECHANOVER, A ;
BEN-NERIAH, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10599-10603
[2]  
ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689
[3]   Modification of vascular responses in xenotransplantation: Inflammation and apoptosis [J].
Bach, FH ;
Ferran, C ;
Soares, M ;
Wrighton, CJ ;
Anrather, J ;
Winkler, H ;
Robson, SC ;
Hancock, WW .
NATURE MEDICINE, 1997, 3 (09) :944-948
[4]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[5]   Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA [J].
Bosserhoff, AK ;
Hein, R ;
Bogdahn, U ;
Buettner, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :490-495
[6]   Therapeutic strategies to reduce TNF-α mediated cardiac contractile depression following ischemia and reperfusion [J].
Cain, BS ;
Harken, AH ;
Meldrum, DR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (05) :931-947
[7]  
CHEN WZ, 1984, ACTA PHARM SIN, V19, P876
[8]   SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY [J].
CHEN, ZJ ;
HAGLER, J ;
PALOMBELLA, VJ ;
MELANDRI, F ;
SCHERER, D ;
BALLARD, D ;
MANIATIS, T .
GENES & DEVELOPMENT, 1995, 9 (13) :1586-1597
[9]   AUTOREGULATION OF I-KAPPA-B-ALPHA ACTIVITY [J].
CHIAO, PJ ;
MIYAMOTO, S ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :28-32
[10]   A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B [J].
DiDonato, JA ;
Hayakawa, M ;
Rothwarf, DM ;
Zandi, E ;
Karin, M .
NATURE, 1997, 388 (6642) :548-554